The cannabis industry is expected to see rapid growth over the coming years. Canada remains the industry leader with its progressive laws governing cannabis, and the market continues to grow in the United States and Europe. There are many different ways for investors to capitalize on these trends, but the best investment opportunities combine short-term revenue and long-term potential.
In this article, we will look at True Leaf Medicine International Ltd. (CSE: MJ) (OTCQB: TRLFF) (FSE: TLA) and its plans to capitalize on the multi-billion dollar cannabis industry through its two wholly-owned subsidiaries, True Leaf Pet and True Leaf Medicine.
Click here to learn about the company’s upcoming Regulation A+ financing opportunity, and to receive an alert when it goes live.